![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1679190
¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå ¿¹Ãø(-2030³â) : ¼Ö·ç¼Ç À¯Çüº°, ¾à±¹ À¯Çüº°, ±¸¼º¿ä¼Òº°, Àü°³ ¹æ½Äº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®Pharmacy Management System Market Forecasts to 2030 - Global Analysis by Solution Type, Pharmacy Type, Component, Deployment Mode, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº 2024³â 816¾ï ´Þ·¯·Î ¿¹Ãø ±â°£ µ¿¾È 12.4%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 1,650¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¾à±¹ °ü¸® ½Ã½ºÅÛ(PMS)Àº Àç°í °ü¸®, ó¹æÀü ÀÛ¼º, û±¸, ±ÔÁ¦ Áؼö µî ¾à±¹ ÇÁ·Î¼¼½º¸¦ °£¼ÒÈÇϰí ÀÚµ¿ÈÇÏ´Â ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÔ´Ï´Ù. ¾à»ç°¡ ¿Ã¹Ù¸¥ Á¶Á¦¸¦ Çϰí, ¾àǰ ¿À·ù¸¦ ÃÖ¼ÒÈÇϸç, ÀǾàǰ Àç°í¸¦ È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¿øÈ°ÇÑ °Å·¡¿Í ȯÀÚ °ü¸®¸¦ À§ÇØ PMS´Â POS ´Ü¸»±â, º¸Çè ½Ã½ºÅÛ, ÀüÀڰǰ±â·Ï(EHR)°ú ¿¬°áµË´Ï´Ù. ÀÚµ¿ ÀçÁÖ¹®, ȯÀÚ ÀÌ·Â ÃßÀû, ºñÁî´Ï½º ÀλçÀÌÆ®¸¦ À§ÇÑ ºÐ¼® µîÀÇ ±â´ÉÀº °í±Þ ½Ã½ºÅÛÀÇ ÇÑ ¿¹ÀÔ´Ï´Ù. ¾à±¹ °ü¸® ½Ã½ºÅÛÀº ¿öÅ©Ç÷οìÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ³ô¿© ¾÷¹« »ý»ê¼ºÀ» ³ôÀ̰í, ºñ¿ëÀ» Àý°¨Çϸç, ȯÀÚ¿Í ÀÇ·á ¼ºñ½º Á¦°øÀÚ¿¡°Ô ´õ ³ªÀº ÀÇ·á °á°ú¸¦ º¸ÀåÇÕ´Ï´Ù.
American College of Clinical Pharmacy¿¡ µû¸£¸é, 2021³â±îÁö ¾à 50¾ï °ÇÀÇ Ã³¹æÀüÀÌ Á¶Á¦µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
µðÁöÅÐ ÇコÄÉ¾î ¼Ö·ç¼Ç µµÀÔ È®´ë
µðÁöÅÐ ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ »ç¿ë È®´ë´Â È¿À²¼º, Á¤È®¼º, ȯÀÚ Ä¡·áÀÇ È¿À²¼ºÀ» Çâ»ó½ÃŰ¸ç ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á, AI ±â¹Ý ºÐ¼®, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°úÀÇ ÅëÇÕÀº ó¹æ °ü¸®¸¦ ¿ëÀÌÇÏ°Ô Çϰí, ½Ç¼ö¸¦ ÁÙÀ̸ç, Àç°í °ü¸®¸¦ °ÈÇÕ´Ï´Ù. ½ÃÀå È®´ë´Â Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç, ½Ç½Ã°£ µ¥ÀÌÅÍ ±³È¯, ÀÚµ¿ÈµÈ ¿öÅ©Ç÷ο쿡 ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¾à±¹ °ü¸® ½Ã½ºÅÛÀº Çö´ëÀÇ ±â¼ú ÁÖµµÇü ÇコÄɾî ȯ°æ¿¡¼ ¸Å¿ì Áß¿äÇϸç, ¾÷°èÀÇ µðÁöÅÐ Çõ½ÅÀÌ ÁøÇàµÊ¿¡ µû¶ó ¾à±¹ °ü¸® ½Ã½ºÅÛÀÇ µµÀÔÀÌ ´õ¿í °¡¼Óȵǰí ÀÖ½À´Ï´Ù.
³ôÀº µµÀÔ ºñ¿ë
³ôÀº µµÀÔ ºñ¿ëÀ¸·Î ÀÎÇØ ¾à±¹ °ü¸® ½Ã½ºÅÛ »ê¾÷, ƯÈ÷ ¼Ò±Ô¸ð µ¶¸³ ¾à±¹¿¡¼ÀÇ Ã¤ÅÃÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ÀáÀç °í°´µéÀº ¼ÒÇÁÆ®¿þ¾î, Çϵå¿þ¾î, ÅëÇÕ, ±³À° ºñ¿ë¿¡ ´ëÇÑ ºÎ´ãÀ¸·Î ÀÎÇØ ¼ÒÇÁÆ®¿þ¾î, Çϵå¿þ¾î, ÅëÇÕ ¹× ±³À° ºñ¿ëÀ» ²¨·ÁÇÏ¿© ½ÃÀå ħÅõ¸¦ ÀúÇØÇϰí ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ À¯Áöº¸¼ö ¹× ¾÷±×·¹ÀÌµå ºñ¿ëÀ¸·Î ÀÎÇØ ¿¹»êÀÌ ´õ¿í ¾Ð¹ÚÀ» ¹Þ°í ÀÖÀ¸¸ç, ´õ Àú·ÅÇÑ ¿É¼ÇÀÌ ´õ¿í ¸Å·ÂÀûÀ¸·Î ´À²¸Áý´Ï´Ù. Á¦¾à »ê¾÷ÀÇ Àü¹ÝÀûÀÎ È¿À²¼º°ú ÀÚµ¿È´Â ÀÌ·¯ÇÑ °æÁ¦Àû À庮¿¡ ÀÇÇØ ¿µÇâÀ» ¹Þ¾Æ ±â¼ú °³¹ßÀÌ Áö¿¬µÇ°í °á±¹ ½ÃÀå °³Ã´ÀÌ Á¦Çѵ˴ϴÙ.
ÀÚµ¿È ¼ö¿ä Áõ°¡
ÀÚµ¿È¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â È¿À²¼ºÀ» ³ôÀ̰í, Åõ¾à ¿À·ù¸¦ ÁÙÀ̸ç, ȯÀÚ Ä¡·á¸¦ °³¼±ÇÔÀ¸·Î½á ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿È ½Ã½ºÅÛÀº ó¹æÀü ó¸®, Àç°í °ü¸®, û±¸ ¾÷¹«¸¦ °£¼ÒÈÇÏ¿© ¼öÀÛ¾÷À» ÁÙÀÌ°í ¿î¿µ ºñ¿ëÀ» Àý°¨Çϸç, AI¿Í Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀÇ ÅëÇÕÀ» ÅëÇØ ¿öÅ©Ç÷ο츦 ´õ¿í ÃÖÀûÈÇÏ°í ½Ç½Ã°£ ÃßÀûÀ» º¸ÀåÇÕ´Ï´Ù. ¾à±¹ÀÇ ¾÷¹«·® Áõ°¡¿Í º¹ÀâÇÑ ±ÔÁ¦ ¿ä°ÇÀ¸·Î ÀÎÇØ ÀÚµ¿È »ç¿ëÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ¾î ¾à±¹ ¾÷¹«¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù.
µ¥ÀÌÅÍ º¸¾È ¹× ÇÁ¶óÀ̹ö½Ã ¹®Á¦
µ¥ÀÌÅÍ À¯Ãâ, ±ÔÁ¦ ¹ÌÁؼö, ȯÀÚ ±â¹Ð Ä§ÇØ µîÀÇ À§ÇèÀ¸·Î ÀÎÇØ µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎÁ¤º¸ º¸È£¿¡ ´ëÇÑ ¿ì·Á·Î ÀÎÇØ ¾à±¹ °ü¸® ½Ã½ºÅÛ ½ÃÀå µµÀÔÀÌ Á¦Çѵǰí ÀÖÀ¸¸ç, HIPAA¿Í °°Àº ¾ö°ÝÇÑ ±ÔÁ¦´Â ÄÄÇöóÀ̾𽺠ºñ¿ëÀ» Áõ°¡½Ã۰í, »çÀ̹ö À§ÇùÀº ÅõÀÚ¸¦ ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù. ÅõÀÚ¸¦ ¾ïÁ¦ÇÕ´Ï´Ù. µ¥ÀÌÅÍ¿¡ ´ëÇÑ ¹«´Ü Á¢±Ù ¹× ¾Ç¿ë¿¡ ´ëÇÑ ¿ì·Á´Â ¾à±¹°ú ȯÀÚÀÇ ½Å·Ú¸¦ ¶³¾î¶ß¸³´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦µéÀº Çõ½ÅÀ» Áö¿¬½Ã۰í, Ŭ¶ó¿ìµå µµÀÔÀ» º¹ÀâÇÏ°Ô ¸¸µé¸ç, ¼Ò±Ô¸ð °ø±ÞÀÚ¿¡°Ô À庮À» ¸¸µé¾î °á±¹ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÕ´Ï´Ù.
COVID-19ÀÇ ¿µÇâ
COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ¾à±¹µéÀÌ Ã³¹æÀü Áõ°¡¿Í ¿ø°ÝÀÇ·á¿ÍÀÇ ÅëÇÕ¿¡ ÀûÀÀÇÏ¸é¼ ¾à±¹ °ü¸® ½Ã½ºÅÛ µµÀÔÀÌ °¡¼ÓȵǾú½À´Ï´Ù. »çȸÀû °Å¸®µÎ±â¿Í »çȸÀû °Å¸®µÎ±â·Î ÀÎÇØ ÀüÀÚó¹æÀü, ÀÚµ¿Á¶Á¦, Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çß½À´Ï´Ù. °ø±Þ¸ÁÀÇ È¥¶õÀ¸·Î ÀÎÇØ ½Ç½Ã°£ Àç°í °ü¸®ÀÇ Çʿ伺ÀÌ ºÎ°¢µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ ÇコÄɾ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿øÀº ½ÃÀå ¼ºÀåÀ» °ÈÇßÀ¸¸ç, ¾à±¹ ÀÚµ¿È´Â ÆÒµ¥¹Í ÀÌÈÄ Áß¿äÇÑ Æ®·»µå°¡ µÇ¾ú½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¼ÒÇÁÆ®¿þ¾î ºÐ¾ß°¡ °¡Àå Ŭ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼ÒÇÁÆ®¿þ¾î ºÎ¹®Àº ¾à¹° °ü¸® °³¼±À¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀüÀÚ Ã³¹æÀü, Àç°í ÃßÀû, ÄÄÇöóÀ̾𽺠°ü¸®¿Í °°Àº °í±Þ ±â´ÉÀº ¾à±¹ ¿î¿µÀ» °£¼ÒÈÇϰí, ¿À·ù¸¦ ÁÙÀ̸ç, ȯÀÚ °á°ú¸¦ °³¼±Çϰí, AI, Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç, µ¥ÀÌÅÍ ºÐ¼®ÀÇ ÅëÇÕÀº ÀÇ»ç°áÁ¤°ú °í°´ ¼ºñ½º¸¦ ´õ¿í Çâ»ó½Ãų °ÍÀÔ´Ï´Ù. ¿ø°Ý ¾à±¹ ¹× µðÁöÅÐ Çコ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¼ÒÇÁÆ®¿þ¾î äÅÃÀ» ÃËÁøÇϰí ÃֽŠ¾à±¹ °ü¸® ½Ã½ºÅÛÀÇ Áß¿äÇÑ ÃËÁøÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È Á¦¾à ȸ»ç ºÎ¹®Àº °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È Á¦¾à ±â¾÷ ºÎ¹®Àº °¡Àå ³ôÀº ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº ÀΰøÁö´É(AI) ¹× Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç°ú °°Àº ÷´Ü ±â¼úÀ» µµÀÔÇÏ¿© ȯÀÚÀÇ ¾ÈÀü°ú ¿öÅ©Ç÷οìÀÇ È¿À²¼ºÀ» ³ôÀ̰í Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀº ÀÚµ¿ ¸®ÇÊ, µðÁöÅРó¹æÀü, ½Ç½Ã°£ ¾à¹° ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾àȸ»ç¿Í ¾à±¹ °ü¸® ½Ã½ºÅÛ Á¦°ø¾÷ü¿ÍÀÇ Á¦ÈÞ¸¦ ÅëÇØ ¿øÈ°ÇÑ µ¥ÀÌÅÍ ±³È¯°ú ¾àǰ ¿À·ù¸¦ ÁÙ¿© Àü¹ÝÀûÀÎ ÇコÄÉ¾î ¼ºñ½º Á¦°øÀ» °ÈÇÒ ¼ö ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â ¿À·ù ¾ø´Â Á¶Á¦¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀüÀÚ Ã³¹æÀü ¹× ÀüÀÚ ÀÇ·á ±â·Ï(EHR)ÀÇ »ç¿ëÀ¸·Î ¾÷¹« È¿À²¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ ¹ß´Þ°ú °í·ÉÈ·Î ÀÎÇØ ÀÚµ¿È ½Ã½ºÅÛ¿¡ ´ëÇÑ ´ÏÁî°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ŭ¶ó¿ìµå ±â¹Ý ±â¼ú°ú AIÀÇ ÅëÇÕÀ¸·Î ȯÀÚ ¾ÈÀü°ú Àç°í °ü¸®°¡ °ÈµÉ °ÍÀÔ´Ï´Ù. ÀÌ Áö¿ªÀÇ »ê¾÷Àº ÇコÄɾî IT¸¦ Áö¿øÇÏ´Â Á¤ºÎ ÇÁ·Î±×·¥°ú ¾à±¹ ÀÚµ¿È¿¡ ´ëÇÑ ÁöÃâ Áõ°¡·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÀüÀÚ Ã³¹æÀü¿¡ ´ëÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡, ¾à±¹ÀÇ ÀÚµ¿ÈµÈ ¿öÅ©Ç÷ο쿡 ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ÇコÄɾî ÀÎÇÁ¶ó È®´ë, °í·ÉÈ Àα¸ Áõ°¡, ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, AI ±â¹Ý Àç°í °ü¸®, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°úÀÇ ÅëÇÕ, Ŭ¶ó¿ìµå ±â¹Ý ¾à±¹ ¼Ö·ç¼ÇÀÇ Àα⠻ó½Â°ú °°Àº ±â¼ú ¹ßÀüÀÌ ÀÌ Áö¿ªÀÇ Ã¤ÅÃÀ» °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Pharmacy Management System Market is accounted for $81.6 billion in 2024 and is expected to reach $165.07 billion by 2030 growing at a CAGR of 12.4% during the forecast period. A Pharmacy Management System (PMS) is a software solution that simplifies and automates pharmacy processes such as inventory management, prescription filling, billing, and regulatory compliance. It assists pharmacists in ensuring correct dispensing, minimizing pharmaceutical errors, and effectively managing drug inventories. For smooth transactions and patient care, PMS connects with point-of-sale (POS) terminals, insurance systems, and electronic health records (EHR). Features like automated reordering, patient history tracking, and analytics for business insights are examples of advanced systems. A Pharmacy Management System increases operational productivity, lowers costs, and guarantees better healthcare outcomes for patients and providers by increasing workflow accuracy and efficiency.
According to the American College of Clinical Pharmacy, around 5 billion prescriptions will be dispensed by 2021.
Growing Adoption of Digital Healthcare Solutions
The increasing usage of digital healthcare solutions is propelling the market by improving efficiency, accuracy, and patient care. Prescription management is made easier, errors are decreased, and inventory control is enhanced by integration with telemedicine, AI-driven analytics, and electronic health records (EHRs). Market expansion is aided by growing demand for cloud-based solutions, real-time data exchange, and automated workflows. Pharmacy management systems are crucial for contemporary, tech-driven healthcare settings, and their adoption is further accelerated by growing digital transformation in the industry.
High Implementation Costs
High implementation costs impede the pharmacy management system industry, limiting adoption, particularly among small and independent pharmacies. Potential customers are turned off by the costs of software, hardware, integration, and training, which lower market penetration. Budgets are further strained by the price of continuous maintenance and upgrades, which increases the appeal of less expensive options. The pharmaceutical industry's total efficiency and automation are impacted by this financial barrier, which slows technical developments and eventually limits market expansion.
Rising Need for Automation
The growing demand for automation is propelling the market by increasing efficiency, lowering medication mistakes, and improving patient care. Automated systems reduce manual involvement and operating expenses by streamlining prescription processing, inventory management, and billing. Workflow is further optimized through the integration of AI and cloud-based solutions, guaranteeing real-time tracking. Automation use is booming as a result of pharmacies' growing workloads and complicated regulatory requirements, which is driving market expansion and revolutionizing pharmacy operations.
Data Security & Privacy Concerns
Data security and privacy concerns hinder the pharmacy management system market by limiting adoption due to risks of data breaches, regulatory non-compliance, and patient confidentiality violations. Strict regulations like HIPAA increase compliance costs, while cyber threats deter investments. Concerns over unauthorized access and data misuse reduce trust among pharmacies and patients. These challenges slow innovation, complicate cloud adoption, and create barriers for smaller providers, ultimately restraining market growth.
Covid-19 Impact
The COVID-19 pandemic accelerated the adoption of Pharmacy Management Systems as pharmacies adapted to increased prescription volumes and telemedicine integration. Lockdowns and social distancing drove demand for e-prescriptions, automated dispensing, and cloud-based solutions. Supply chain disruptions highlighted the need for real-time inventory management. Additionally, regulatory support for digital healthcare strengthened market growth, making pharmacy automation a key post-pandemic trend.
The software segment is expected to be the largest during the forecast period
The software segment is expected to account for the largest market share during the forecast period, due to improving medication management. Advanced features like electronic prescriptions, inventory tracking, and compliance management streamline pharmacy operations, reducing errors and improving patient outcomes. The integration of AI, cloud-based solutions, and data analytics further boosts decision-making and customer service. Growing demand for telepharmacy and digital health solutions fuels software adoption, making it a crucial growth driver in modern pharmacy management systems.
The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceutical companies segment is predicted to witness the highest growth rate, as these businesses incorporate cutting-edge technology like artificial intelligence (AI) and cloud-based solutions to enhance patient safety and workflow effectiveness. The market is growing as a result of growing demand for automated refills, digital prescriptions, and real-time drug monitoring. Furthermore, pharmaceutical companies' partnerships with pharmacy management system providers enable smooth data interchange and lowering drug mistakes, which enhances the provision of healthcare services generally.
During the forecast period, the North America region is expected to hold the largest market share due to the growing need for medicine dispensing that is error-free. Operational efficiency is increased by the use of e-prescriptions and electronic health records (EHRs). The need for automated systems is fueled by the development of chronic diseases and the aging population. Furthermore, cloud-based technologies and AI integration enhance patient safety and inventory management. The region's industry is growing due to government programs that boost healthcare IT and growing expenditures in pharmacy automation.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to increasing government initiatives for e-prescriptions, and the rising demand for automated workflows in pharmacies. The expanding healthcare infrastructure, coupled with a growing aging population and rising chronic disease prevalence, fuels market growth. Additionally, technological advancements such as AI-powered inventory management, integration with electronic health records (EHRs), and the rising popularity of cloud-based pharmacy solutions are accelerating adoption across the region.
Key players in the market
Some of the key players profiled in the Pharmacy Management System Market include McKesson Corporation, Cerner Corporation, Becton Dickinson and Co., GE Healthcare Inc., Talyst LLC, Allscripts Healthcare Solutions Inc., Epicor Software Corporation, Omnicell Inc., ACG Infotech Ltd., Clanwilliam Health Ltd., DATASCAN (DCS Pharmacy Inc.), GlobeMed Ltd., Health Business Systems Inc., Idhasoft Ltd., MedHOK Inc. and Octal IT Solution LLP.
In February 2025, McKesson Corporation announced that it signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC, to build on leadership in community practice and specialty solutions, while building a platform to serve the high-growth area of retina and ophthalmology.
In October 2024, McKesson Corporation announced the launch of InspiroGeneTM by McKesson ("InspiroGene"), a dedicated business focused solely on supporting the commercialization of cell and gene therapies (CGTs).
In April 2024, McKesson Corporation announced the launch of Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.